|
Pluristem Therapeutics
PSTI
|
$ 1.03 |
-1.9 % |
$ 33.3 M |
Nasdaq Global Select Market |
Israel |
|
Cortexyme
CRTX
|
$ 1.88 |
-1.05 % |
$ 67.1 M |
Nasdaq Global Select Market,SPB |
USA |
|
Sorrento Therapeutics
SRNE
|
$ 0.27 |
-29.58 % |
$ 126 M |
Nasdaq Global Select Market |
USA |
|
Caladrius Biosciences
CLBS
|
$ 0.43 |
-16.75 % |
$ 25.8 M |
Nasdaq Capital Market |
USA |
|
ContraFect Corporation
CFRX
|
$ 1.47 |
-5.16 % |
$ 5.39 M |
Nasdaq Capital Market |
USA |
|
Orchard Therapeutics plc
ORTX
|
$ 4.93 |
1.02 % |
$ 90.8 M |
Nasdaq Global Select Market |
Britain |
|
AstraZeneca PLC
AZN
|
$ 76.32 |
0.74 % |
$ 96.9 B |
Nasdaq Global Select Market |
Britain |
|
Advaxis
ADXS
|
$ 0.31 |
-9.65 % |
$ 45.9 M |
Nasdaq Capital Market |
USA |
|
Heat Biologics, Inc.
HTBX
|
$ 3.93 |
-5.76 % |
$ 99.8 M |
Nasdaq Capital Market |
USA |
|
La Jolla Pharmaceutical Company
LJPC
|
$ 6.2 |
- |
$ 154 M |
Nasdaq Capital Market |
USA |
|
Zymeworks
ZYME
|
$ 6.42 |
- |
$ 404 M |
NYSE |
Canada |
|
BELLUS Health
BLU
|
$ 14.74 |
- |
$ 2.47 B |
Nasdaq Global Select Market |
Canada |
|
Cara Therapeutics
CARA
|
$ 0.79 |
0.28 % |
$ 42.8 M |
Nasdaq Global Market,SPB |
USA |
|
Checkmate Pharmaceuticals
CMPI
|
$ 10.5 |
- |
$ 231 M |
Nasdaq Global Market |
USA |
|
Cerevel Therapeutics Holdings
CERE
|
$ 42.26 |
-0.61 % |
$ 6.85 B |
Nasdaq Capital Market |
USA |
|
CEL-SCI Corporation
CVM
|
$ 1.67 |
-2.91 % |
$ 79.2 M |
NYSE American,SPB |
USA |
|
Kadmon Holdings, Inc.
KDMN
|
$ 9.5 |
- |
$ 1.7 B |
Nasdaq Global Select Market |
USA |
|
AIkido Pharma
AIKI
|
$ 3.17 |
1.93 % |
$ 17.4 M |
Nasdaq Capital Market |
USA |
|
BioDelivery Sciences International
BDSI
|
$ 2.58 |
-4.8 % |
$ 255 M |
Nasdaq Global Select Market |
USA |
|
Zosano Pharma Corporation
ZSAN
|
$ 0.56 |
7.23 % |
$ 2.72 M |
Nasdaq Global Select Market |
USA |